Skip to content
OpenCapital
Get started

Citius Pharmaceuticals CTXR Q4 2024 Annual earnings

Reported February 14, 2025 · Before market open

Diluted EPS-$1.30Miss by $0.05
Revenue estimate$2.7M
EPS estimate-$1.25

Next report

Aug 11, 2026 (in a month)
Revenue estimate$5.5M
EPS estimate-$0.36

Versus estimates

Revenue

Q1 2026$1.7MMiss by $8.6MQ4 2025$3.9MMiss by $14.1MQ3 2025$3.9M

Diluted EPS

Q1 2026-$0.95Miss by $0.67Q4 2025-$0.38Miss by $0.81Q3 2025-$0.44Miss by $0.20Q2 2025-$0.80Miss by $0.56Q1 2025-$1.27Miss by $0.19
Q4 2024-$1.30Miss by $0.05

Ask the moment Citius Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Citius Pharmaceuticals report Q4 2024 earnings?
Citius Pharmaceuticals (CTXR) reported Q4 2024 earnings on February 14, 2025 before market open.
What were Citius Pharmaceuticals's Q4 2024 revenue and EPS?
Citius Pharmaceuticals reported diluted EPS of $-1.30 for Q4 2024.
Did Citius Pharmaceuticals beat estimates in Q4 2024?
EPS missed the consensus estimate of $-1.25 by $0.05.
Where can I find Citius Pharmaceuticals's Q4 2024 SEC filings?
You can read the 10-K/A periodic report (0001213900-25-006997) directly on SEC EDGAR. The filing index links above go to sec.gov.